We find that CDK5 activators, p35/p39 have increased expression in NPC disease and inhibition of CDK5 kinase activity with roscovitine abrogates enhancement of both KV2.1 and CaV1.2 clustering in the PM of NPC neurons. Here, CDK5 is linked to nasopharyngeal carcinoma.